Objective: We designed a longitudinal cohort study on People with Epilepsy (PwE) with the aim of assessing the effect of Perampanel (PER) on cortico-subcortical networks, as measured by high-frequency oscillations of somatosensory evoked potentials (SEP-HFOs). SEP-HFOs measure the excitability of both thalamo-cortical projections (early HFOs) and intracortical GABAergic synapses (late HFOs), thus they could be used to study the anti-glutamatergic action of PER, a selective antagonist of the AMPA receptor.Methods: 15 PwE eligible for PER add-on therapy, were enrolled prospectively. Subjects underwent SEPs recording from the dominant hand at two times: PwE(T0) (baseline, before PER titration) and PwE(T1) (therapeutic dose of 4 mg). HFOs were obtained by filtering N20 scalp response in the 400-800 Hz range. Patients were compared with a normative population of 15 healthy controls (HC) matched for age and sex.Results: We found a significant reduction of Total HFOs and mostly early HFOs area between PwE(T0) and PwE(T1) (p = 0.05 and p = 0.045 respectively) and between HC and PwE(T1) (p = 0.01). Furthermore, we found a significant reduction of P24/N24 Amplitude between PwE(T0) and HC and between PwE(T0) and PwE(T1) (p = 0.006 and p = 0.032, respectively).Conclusions: Introduction of PER as add-on therapy reduced the area of total HFOs, acting mainly on the early burst, related to thalamo-cortical pathways. Furthermore P24/N24 amplitude, which seems to reflect a form of cortico-subcortical integration, resulted increased in PwE at T0 and normalized at T1.Significance: Our findings suggest that PER acts on cortico-subcortical excitability. This could explain the broad spectrum of PER and its success in forms of epilepsy characterized by thalamo-cortical hyperexcitability. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Effects of the noncompetitive AMPA receptor antagonist perampanel on thalamo-cortical excitability: A study of high-frequency oscillations in somatosensory evoked potentials

Boscarino, Marilisa;Tombini, Mario;Di Lazzaro, Vincenzo;Assenza, Giovanni
2021-01-01

Abstract

Objective: We designed a longitudinal cohort study on People with Epilepsy (PwE) with the aim of assessing the effect of Perampanel (PER) on cortico-subcortical networks, as measured by high-frequency oscillations of somatosensory evoked potentials (SEP-HFOs). SEP-HFOs measure the excitability of both thalamo-cortical projections (early HFOs) and intracortical GABAergic synapses (late HFOs), thus they could be used to study the anti-glutamatergic action of PER, a selective antagonist of the AMPA receptor.Methods: 15 PwE eligible for PER add-on therapy, were enrolled prospectively. Subjects underwent SEPs recording from the dominant hand at two times: PwE(T0) (baseline, before PER titration) and PwE(T1) (therapeutic dose of 4 mg). HFOs were obtained by filtering N20 scalp response in the 400-800 Hz range. Patients were compared with a normative population of 15 healthy controls (HC) matched for age and sex.Results: We found a significant reduction of Total HFOs and mostly early HFOs area between PwE(T0) and PwE(T1) (p = 0.05 and p = 0.045 respectively) and between HC and PwE(T1) (p = 0.01). Furthermore, we found a significant reduction of P24/N24 Amplitude between PwE(T0) and HC and between PwE(T0) and PwE(T1) (p = 0.006 and p = 0.032, respectively).Conclusions: Introduction of PER as add-on therapy reduced the area of total HFOs, acting mainly on the early burst, related to thalamo-cortical pathways. Furthermore P24/N24 amplitude, which seems to reflect a form of cortico-subcortical integration, resulted increased in PwE at T0 and normalized at T1.Significance: Our findings suggest that PER acts on cortico-subcortical excitability. This could explain the broad spectrum of PER and its success in forms of epilepsy characterized by thalamo-cortical hyperexcitability. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
2021
Epilepsy; HFO; High frequency oscillations; Perampanel; SEP; Somatosensory evoked potentials; Thalamus; Adult; Anticonvulsants; Cerebral Cortex; Epilepsy; Female; Humans; Male; Middle Aged; Nitriles; Pyridones; Receptors, AMPA; Thalamus; Evoked Potentials, Somatosensory
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12610/69965
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact